SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-05-021379
Filing Date
2005-11-14
Accepted
2005-11-14 06:19:10
Documents
7
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a14338e10vq.htm 10-Q 245349
2 EXHIBIT 10.186 a14338exv10w186.htm EX-10.186 49299
3 EXHIBIT 10.187 a14338exv10w187.htm EX-10.187 33159
4 EXHIBIT 31.1 a14338exv31w1.htm EX-31.1 8110
5 EXHIBIT 31.2 a14338exv31w2.htm EX-31.2 8354
6 EXHIBIT 32.1 a14338exv32w1.htm EX-32.1 3016
7 EXHIBIT 32.2 a14338exv32w2.htm EX-32.2 3027
  Complete submission text file 0000950134-05-021379.txt   351709
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18006 | Film No.: 051195943
SIC: 2836 Biological Products, (No Diagnostic Substances)